Quest Diagnostics
Open
$193.71
Prev. Close
$194.00
High
$193.71
Low
$193.71
Market Snapshot
$20.8B
20.3
7.78
$9.87B
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 46,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
emptyResult
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 46,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Recently from Cashu

Quest Diagnostics Enhances Drug Screening Services to Meet Regulatory Demands and Market Opportunities
Quest Diagnostics significantly enhances its drug screening capabilities to meet evolving regulatory demands and capitalize on market opportunities. Innovative Drug Screening Enhancements The company…
Quali and NVIDIA Transform AI Workflows for Quest Diagnostics in Healthcare
Transforming AI Workflows in Diagnostics: Quali's Integration with NVIDIA In the fast-evolving landscape of artificial intelligence and healthcare diagnostics, the integration of Quali's Torque platfo…
Quest Diagnostics Drives AI Integration Through Strategic Partnerships in Healthcare Diagnostics
Quest Diagnostics Leverages AI Workflows Through Strategic Collaborations In recent developments within the healthcare diagnostics sector, Quest Diagnostics stands at the forefront of integrating adva…
Quest Diagnostics Appoints Timothy Wentworth to Strengthen Board Leadership and Strategic Direction
Quest Diagnostics Strengthens Leadership with New Board Appointment Quest Diagnostics Incorporated, a leading provider of diagnostic information services, enhances its leadership team by appointing Ti…